Key TakeawaysAfter a tough year for Walgreens investors in 2024, shares may have appeared poised to start 2025 on strong note after the company's first-quarter results topped expectations.However, analysts have remained cautious, mostly keeping "hold" or "sell" ratings on the pharmacy retailer's stock.A lawsuit filed late last week by the Department of Justice sent shares lower Tuesday, adding to the company's challenges. After a tough year for Walgreens (WBA) investors in 2024, shares may have appeared poi ...

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Walgreens Boots Alliance, Inc. due to allegations of materially misleading business information [1] Group 1: Legal Investigation - The investigation is prompted by allegations that Walgreens knowingly filled millions of prescriptions for controlled substances without a legitimate medical purpose from August 2012 to the present [3] - Following the announcement from the U.S. Department of Justice, Walgreens' stock price fell in aftermarket trading on January 17, 2025 [3] Group 2: Class Action Details - Investors who purchased Walgreens securities may be entitled to compensation through a class action lawsuit, with no out-of-pocket fees or costs due to a contingency fee arrangement [2] - Interested investors can join the class action by submitting a form or contacting the Rosen Law Firm directly [2] Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time [4] - The firm has been ranked in the top 4 for securities class action settlements since 2013 and recovered hundreds of millions of dollars for investors, including over $438 million in 2019 [4]

Key TakeawaysThe S&P 500 added 0.9% on Tuesday, Jan. 21, the first day of trading following President Donald Trump's return to the White House.Oracle stock surged following reports that the software giant would participate in a massive joint venture to build out AI infrastructure in the U.S.Walgreens shares plunged as the Justice Department filed a lawsuit claiming the pharmacy chain had dispensed prescriptions with no legitimate medical basis. Major U.S. equities indexes advanced as the markets kicked off ...

Key TakeawaysWalgreens Boots Alliance shares tumbled Tuesday after Department of Justice allegations that its pharmacies dispensed prescriptions with no legitimate medical reasoning.The DOJ filed a lawsuit late last week accusing the pharmacy of handing out "millions of unlawful prescriptions" for dangerous opioids, among other drugs.Walgreens said the government is trying to put its pharmacists in a "no-win situation." Walgreens Boots Alliance (WBA) shares sank Tuesday, the first day of trading since the D ...

Shares of Walgreens Boots Alliance (WBA -13.61%) pulled back today after the company again ran into trouble with regulators.On Friday, the Department of Justice (DOJ) filed a lawsuit against Walgreens, alleging that it dispensed "millions of unlawful prescriptions."As of 10:26 a.m. ET, the stock was down 12.7% on the news. Walgreens gets another red flagWalgreens already made a multibillion-dollar settlement over opioid prescriptions two years ago. It agreed to pay $5.7 billion over 15 years, and now it cou ...

Last week, the U.S. Department of Justice filed a civil complaint against Walgreens Boots Alliance Inc WBA and its subsidiaries, alleging widespread violations of the Controlled Substances Act (CSA) and False Claims Act (FCA).In a statement, Walgreens said, “We are asking the court to clarify the responsibilities of pharmacies and pharmacists and to protect against the government’s attempt to enforce arbitrary “rules” that do not appear in any law or regulation and never went through any official rulemaking ...

Core Viewpoint - The law firm Bronstein, Gewirtz & Grossman, LLC has announced an investigation into Walgreens Boots Alliance, Inc. (WBA) and is encouraging stockholders to learn more about the investigation [1] Group 1 - The investigation is focused on potential violations of federal securities laws by Walgreens Boots Alliance, Inc. [1] - Stockholders are urged to contact the law firm for more information regarding the investigation [1] - The announcement indicates that the investigation may relate to the company's financial disclosures and business practices [1]

Bronstein, Gewirtz & Grossman, LLC Encourages Walgreens Boots Alliance, Inc. (WBA) Investors to Inquire about Securities Investigation ...

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Walgreens Boots Alliance, Inc. Investors to Inquire About Securities Class Action Investigation - WBA ...

About this content About Josh Lamb After graduating from the University of Kent in the summer of 2022 with a degree in History, Josh joined Proactive later that year as a journalist in the UK editorial team. Josh has reported on a range of areas whilst at Proactive, including energy companies during a time of global crisis, aviation and airlines as the sector recovers from the pandemic, as well as covering economic, social and governance issues. Read more About the publisher Proactive financial news and ...